SLC7A11 and cancer: Importantly, we verified a toxic gain-of-function mechanism of toxicity based on selenide toxicity, as preemptive KO of SLC7A11, while also abrogating selenoprotein production similarly to SEPHS2 KO, prevented the toxicity of SEPHS2 KO in cancer cells.